the clinical efficacy and electropharmacologic effects of continuous intravenous ( i.v . ) amiodarone infusion ( 10 to 20 mg/kg/day for 4 to 7 days ) followed by chronic oral amiodarone therapy ( 400 to 800 mg/day for 24 to 53 days ) were evaluated in 17 patients with refractory sustained ventricular tachycardia ( vt ) or ventricular fibrillation .
C0002598
amiodarone
C0042510
ventricular fibrillation